Industry news

Despite blockbuster boasts for R&D work, pressure increases on Pfizer to do a megadeal

John Carroll / Endpoints News

Some new products like Ibrance are gaining ground in the marketplace, helping Pfizer weather the storm of generic competition. But sales declined in Q2 as Prevnar revenue weakened and competition loomed for Viagra and Lyrica. And that will have analysts looking to see what CEO Ian Read will do next to right the course at the pharma giant; whether that’s big deals, new cost-cutting efforts, a company breakup, or a mix of all of the above.

New technology will make vaccines quality control in Russia 300 times faster

GMP News

National Immunobiological Company (Nacimbio) introduces a new technology to control the quality of anti-TB vaccines that cuts the period of procedure from one month to 1.5 hours. The technology is developed and tested in the Stavropol branch of NPO Microgen, a part of Nacimbio, and will increase the volume and speed of manufacturing BCG and BCG-M vaccines.

01 August 2017

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2017 Financial Results

Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the "Company"), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update and reported its financial results for the quarter ended June 30, 2017.

The global rivalry for top scientific talent in biopharma R&D is about to get a lot hotter

John Carroll / Endpoints News

Tony Ho was a key player in AstraZeneca’s oncology R&D group, helping lead successful Phase III studies for Lynparza and Imfinzi — two of its top new drugs. But the senior vice president has moved on to another company now, AstraZeneca confirms for me, underscoring a significant migration of top R&D talent that will soon see growing competition among the top players for the best scientists in drug development.

A new type of nanofibrous biopolymer materials is created in Russia

GMP News

The researchers at G.V. Plekhanov Russian University of Economics, together with their colleagues from N.M. Emanuel Institute of Biochemical Physics of RAS and N.N. Semenov Institute of Chemical Physics of RAS, have obtained a new type of nanofibrous biopolymer materials. These materials have unique properties and can be used to manufacture the shells and capsules of medicinal products, bactericidal dressings, filtering and protective materials, as well as for bioresorbable implants (being replaced with bone tissue over time).

Veronika Skvortsova – Russian vaccines are recognized globally

GMP News

“There is a great progress in the creation of Russian vaccines. Over the past 4-5 years, we made a complete transition to Russian-made flu vaccines. They are recognized as the best in the world, and they are currently being purchased in Latin, Central and South America,” said the Minister of Health of the Russian Federation Veronika Skvortsova.

A Drug Program That Keeps Patients Safe (And Profits, Too)

Cynthia Koons / Bloomberg

For generic drug companies, manufacturing low-cost alternatives to brand-name medicines is the easy part. The hard part: getting their hands on the drugs they want to copy.

U.S. CRISPR rights battle heats up as UC team launches appeal

Phil Taylor / FierceBiotech

Enthusiasm about the therapeutic potential of CRISP-Cas9 seems to be matched only by the bitterness of the fight over intellectual property rights to the technology.

Russian technology receives a grant for research and implementation in the USA

GMP News

The industrial partnership program of the US state of Maryland (MIPS) awarded a grant for research of innovative technology created by Russian scientists.

It's elementary, pharma. Periodic table twist on marketing lays out multichannel basics

Beth Snyder Bulik / FiercePharmaMarketing

Pharma marketing gets down to an atomic level in a new vision from Owen Health. The U.K.-based agency charted a marketing twist on the well-known scientific table, using key pharma marketing elements instead of chemical ones.